Cogent Biosciences, Inc.
COGT
$34.34
-$0.03-0.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.89% | -14.58% | -24.73% | -23.37% | -24.95% |
| Total Depreciation and Amortization | 2.98% | 4.56% | 7.13% | 6.75% | 39.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.70% | 149.49% | -20.63% | 13.20% | 61.80% |
| Change in Net Operating Assets | 111.67% | -64.46% | 204.15% | -45.38% | -122.88% |
| Cash from Operations | -30.59% | -23.66% | -27.73% | -26.62% | -37.46% |
| Capital Expenditure | -981.33% | 76.79% | 11.49% | -681.43% | 76.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -621.42% | -356.31% | 110.70% | 6,177.02% | 471.51% |
| Cash from Investing | -623.37% | -357.61% | 110.53% | 6,545.50% | 487.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 37,063.78% | -93.79% | -88.33% | -- |
| Repurchase of Common Stock | -322.46% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -319.98% | -- | 93.97% | -- | -- |
| Cash from Financing | 2,264,011.54% | 34,734.46% | 18,548.05% | -88.33% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16,578.13% | -122.26% | 101.25% | -82.88% | 103.34% |